Performance of a rheumatoid arthritis records-based index of severity

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1679-1687

  Ting, Gladys ^a   Schneeweiss, Sebastian ^a   Katz, Jeffrey N ^b   Weinblatt, Michael E ^b   Cabral, Danielle ^a   Scranton, Richard E ^c   Solomon, Daniel H ^a,b,d  

^a Division of Pharmacoepidemiology and Pharmacoeconomics   (United States)

^b Division of Rheumatology   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Disease severity; Epidemiology; Medical records; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

AGE; AGED; BIOLOGICAL THERAPY; DISEASE SEVERITY; DRUG SAFETY; FEMALE; GENDER; HEALTH STATUS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PERFORMANCE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOGRAPHY; REVIEW; RHEUMATOID ARTHRITIS; SOLDIER; VALIDATION PROCESS;

ACTIVITIES OF DAILY LIVING; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LINEAR MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANGE OF MOTION, ARTICULAR; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME;

EID: 24944445889     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Robbins S, Cotran R, Kumar V. Basic pathology. 7th ed. Philadelphia: W.B. Saunders; 2003.
2. Klippel JH, Weyand CM, Worthmann RL, editors. Primer on the rheumatic diseases. 11th ed. Atlanta: Arthritis Foundation; 1997.
3. Baecklund E, Anders, E, Sparen P, Feltelius N, Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 1998;317:180-1.
4. Beauparlant P, Papp K, Haroaoui B. The incidence of cancer associated with the treatment of rheumatoid arthritis. Semin Arthritis Rheum 1999;29:148-58.
5. Gridley G, McLaughlin JK, Anders E, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
6. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J Chron Dis 1978;31:691-6.
7. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
8. Hochberg MC, Spector T. Epidemiology of rheumatoid arthritis: update. Epidemiol Rev 1990;12:247-52.
9. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
10. Matteson EL, Hickey AR, Maguire L, et al. Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD registry. J Rheumatol 1991;18:809-14.
11. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985;78 Suppl:44-9.
12. Walker AM. Confounding by indication. Epidemiology 1996;7:335-6.
13. Cabral D, Katz JN, Weinblatt M, et al. Assessing indicators of severe rheumatoid arthritis: a Delphi Panel approach. Arthritis Care Res 2004;53:61-6.
14. Navarro-Cano G, del Rincon I, Pogosian S, Roldan JF, Escalante A. Association of mortality with disease severity in rheumatoid arthritis, independent of comorbidity. Arthritis Rheuma 2003;48:2425-33.